Fennec Pharmaceuticals (RV41.F) Q3 2025 Earnings

14AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.2
-0.14
-0.09
-0.03

Details

Expected EPS
-0.029917475575260002
Actual EPS
-0.09564223467942
Surprise EPS
-0.07
Surprise Percent
+219.69%

Description

Fennec Pharmaceuticals (RV41.F) has reported earnings of -0.09564223467942 per share for Q3 2025.

0 Comments

Share your thoughts